TD Securities initiated coverage of Aurora Cannabis (ACB) with a Buy rating and C$9 price target The company “has turned over a proverbial new leaf” following the reset in the cannabis industry, now with a focus on “responsible growth,” the analyst tells investors in a research note. The firm says Aurora’s current valuation presents a “compelling” risk/reward trade-off despite “lingering risk”s in the emerging cannabis industry. It expects improved earnings and valuation to push the share price towards its price target
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACB:
- Rising High: Cannabis firms report quarterly earnings
- Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
- Largest borrow rate increases among liquid names
- Rising High: Exclusive talk with house of brands Carma HoldCo
- Aurora Cannabis Reports Strong Q2 2025 Earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
